These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23290777)

  • 1. Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.
    Liu YY; Hill RA; Li YT
    Adv Cancer Res; 2013; 117():59-89. PubMed ID: 23290777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
    Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM
    Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
    Kartal Yandım M; Apohan E; Baran Y
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide glycosylation potentiates cellular multidrug resistance.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer.
    Madigan JP; Robey RW; Poprawski JE; Huang H; Clarke CJ; Gottesman MM; Cabot MC; Rosenberg DW
    Exp Cell Res; 2020 Mar; 388(2):111860. PubMed ID: 31972222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells.
    Gupta V; Bhinge KN; Hosain SB; Xiong K; Gu X; Shi R; Ho MY; Khoo KH; Li SC; Li YT; Ambudkar SV; Jazwinski SM; Liu YY
    J Biol Chem; 2012 Oct; 287(44):37195-205. PubMed ID: 22936806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells.
    Liu YY; Patwardhan GA; Bhinge K; Gupta V; Gu X; Jazwinski SM
    Cancer Res; 2011 Mar; 71(6):2276-85. PubMed ID: 21278235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
    Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC
    J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo.
    Khiste SK; Hosain SB; Dong Y; Uddin MB; Roy KR; Hill RA; Liu Z; Liu YY
    Sci Rep; 2017 Jun; 7(1):2976. PubMed ID: 28592871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation.
    Baran Y; Bielawski J; Gunduz U; Ogretmen B
    J Cancer Res Clin Oncol; 2011 Oct; 137(10):1535-44. PubMed ID: 21833718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis.
    Liu YY; Han TY; Giuliano AE; Ichikawa S; Hirabayashi Y; Cabot MC
    Exp Cell Res; 1999 Nov; 252(2):464-70. PubMed ID: 10527636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.
    Gupta V; Patwardhan GA; Zhang QJ; Cabot MC; Jazwinski SM; Liu YY
    J Lipid Res; 2010 Apr; 51(4):866-74. PubMed ID: 19826105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for ceramide in driving cancer cell resistance to doxorubicin.
    Liu YY; Yu JY; Yin D; Patwardhan GA; Gupta V; Hirabayashi Y; Holleran WM; Giuliano AE; Jazwinski SM; Gouaze-Andersson V; Consoli DP; Cabot MC
    FASEB J; 2008 Jul; 22(7):2541-51. PubMed ID: 18245173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
    Turzanski J; Grundy M; Shang S; Russell N; Pallis M
    Exp Hematol; 2005 Jan; 33(1):62-72. PubMed ID: 15661399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
    Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
    Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gb3-cSrc complex in glycosphingolipid-enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β-catenin-activated RNA methylation.
    Roy KR; Uddin MB; Roy SC; Hill RA; Marshall J; Li YT; Chamcheu JC; Lu H; Liu YY
    FASEB Bioadv; 2020 Nov; 2(11):653-667. PubMed ID: 33205006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs.
    Veldman RJ; Mita A; Cuvillier O; Garcia V; Klappe K; Medin JA; Campbell JD; Carpentier S; Kok JW; Levade T
    FASEB J; 2003 Jun; 17(9):1144-6. PubMed ID: 12692077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.
    Itoh M; Kitano T; Watanabe M; Kondo T; Yabu T; Taguchi Y; Iwai K; Tashima M; Uchiyama T; Okazaki T
    Clin Cancer Res; 2003 Jan; 9(1):415-23. PubMed ID: 12538495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced UDP-glucose Levels Are Associated with P-glycoprotein Over-expression in L1210 Cells and Limit Glucosylceramide Synthase Activity.
    Turáková K; Pavlíková L; Messingerová L; Lakatoš B; Breier A; Sulová Z
    Anticancer Res; 2015 May; 35(5):2627-34. PubMed ID: 25964538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.